Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Allometric Scaling of M-Mode Cardiac Measurements in Normal Adult Dogs
2004 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Allometric Scaling of M‐Mode Cardiac Measurements in Normal Adult Dogs
2004 Standout
Myocardial perfusion in patients with total occlusion of a single coronary artery with and without collateral circulation
2001
The FGF family: biology, pathophysiology and therapy
2009 Standout
Atopic dermatitis
2003 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs
2001
Exercise Standards for Testing and Training
2013 Standout
The Role of Stress Echocardiography in Valvular Heart Disease: A Current Appraisal
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
1994
Amyloid and amyloidosis
1988
Acute Effects of Nicotine Infusion on Platelets in Nicotine Users with Normal and Impaired Renal Function
2000 StandoutNobel
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
2004 Standout
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Intravascular Stents in Congenital Heart Disease: Short- and Long-Term Results From a Large Single-Center Experience
1998
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study
2004
Myocarditis
2011 Standout
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
2002
Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene
1997 StandoutNobel
Left ventricular systolic function in aortic stenosis
1988
ADP activation induces bFGF binding to platelets in vitro
2002 StandoutNobel
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
1990 Standout
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
2010 Standout
Hemodialysis and the Heart
1995
Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients
2001 Standout
Informational Contribution of Noninvasive Screening Tests for Coronary Artery Disease in Patients on Chronic Renal Replacement Therapy
2001
Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans
1992
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
Methods for Staining Amyloid in Tissues: A Review
1988
Mechanism of postextrasystolic potentiation in the right ventricle
1990
Prevalence and Prognostic Significance of Exercise-Induced Right Bundle Branch Block
2010
Kidney Transplantation and Enzyme α-Galactosidase A Therapy in Patient With Fabry Disease: A Case Report
2007
POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition
2004 Standout
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
2006 Standout
Coronary collateral recruitment: Functional significance and relation to rate of vessel closure
1991
Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil
1976
Candida Infections of Medical Devices
2004 Standout
Valve replacement in aortic insufficiency with left ventricular dysfunction.
1980
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.
1994
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Verapamil
1978
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
2000 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure.
1980
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Serial changes in left ventricular function after correction of chronic aortic regurgitation
1983
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
1992 Standout
Pacemaker lead complications: when is extraction appropriate and what can we learn from published data?
2001
Development and regression of left ventricular hypertrophy
1984
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony.
1989 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.
1993
Decreased Coronary Reserve
1982
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Valve replacement should not be performed in all asymptomatic patients with severe aortic incompetence
1980
Mechanisms of Diabetic Complications
2013 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
In vivo hemodynamic comparison of porcine and pericardial valves
1985
Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy
2003
Cardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
1992
Effect of intermittent left bundle branch block on left ventricular performance in the normal heart
1977
Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem
1980 Standout
Reversal of Left Ventricular Hypertrophy in Essential Hypertension
1996
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth Factor
1992 Science
Hemodynamic and angiographic evaluation of aortic regurgitation 8 and 27 months after aortic valve replacement.
1981
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications
1980
The effect of aortic valve replacement on survival.
1982
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine.
1984 StandoutNobel
Implantation of balloon-expandable stents for coarctation of the aorta: Implantation data and short-term results
1996
Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation
1981
Works of J Thormann being referenced
The vasopressor system in patients with heart failure due to idiopathic dilated cardiomyopathy-influence of the clinical stage of disease and of chronic drug treatment
1989
Left ventricular muscle mass and diastolic function in patients with essential hypertension under long‐term clonidine monotherapy
1991
Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: Improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia
1983
Recovery from myocardial failure after aortic valve replacement
1978
Vagal tone, significance of electrophysiologic findings and clinical course in symptomatic sinus node dysfunction
1978
The pharmacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effects.
1975
Thrombotic complications with pacemakers
1983
Electrophysiological findings in frequency-dependent left bundle-branch block.
1974
AR-L115BS in the treatment of heart failure.
1982
Acute Effects of Dialysis on Myocardial Contractility: Influence of Cardiac Status and Calcium/Potassium Ratio
2015
Mechanisms of altered myocardial contractility during hemodialysis: Importance of changes in the ionized calcium to plasma potassium ratio
1985
Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation
1985
Cardiac dysfunction in patients on maintenance hemodialysis. II. Systolic and diastolic properties of the left ventricle assessed by invasive methods.
1986
Hemodynamics alterations induced by isoproterenol and pacing after aortic valve replacement with the Björk-Shiley or St. Jude medical prosthesis.
1981
Cardiac dysfunction in patients on maintenance hemodialysis. I. The importance of associated heart diseases in determining alterations of cardiac performance.
1986
Influence of fluid removal rate during hemodialysis on left ventricular performance and exercise tolerance in patients with coronary artery disease.
1984
Frequency potentiation and postextrasystolic potentiation in patients with and without coronary arterial disease.
1975
Clinical Trial Comparing Hydrocortisone 17-Butyrate to Betamethasone 17-Valerate in a Series of Patients with Eczematous Skin Diseases
1976
Comparison of myocardial flow, hemodynamic changes, and lactate metabolism during isoproterenol stress in patients with coronary heart disease and severe aortic stenosis
1979
Cardiac reserve during isoproterenol stress in patients with aortic valve disease before and after corrective surgery
1978
Effect of coronary collaterals on left ventricular function at rest and during stress
1978
Cardiac Amyloid Deposits in Endomyocardial Biopsies: Light Microscopic, Ultrastructural, and Immunohistochemical Studies
1986
Cardiac Arrhythmias in Patients on Maintenance Hemodialysis: Causes and Management
2015